Nkarta’s $240 Million Common Stock Offering

O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters.Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now